Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes
NCT06981442 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2050
Last updated 2025-05-20
Summary
Arboviral diseases are viral diseases transmitted by mosquitoes of the Aedes genus and are constantly spreading throughout the world, constituting a significant threat to public health.
In Africa, there is very little data on the epidemiological situation of Aedes-borne diseases and programs for monitoring these diseases are very limited. In the Democratic Republic of the Congo (DRC), several epidemics of yellow fever, dengue fever, chikungunya and Zika cases have been reported. In particular, in Kinshasa, the dengue and chikungunya viruses have previously been detected in patients with undifferentiated fevers and several studies have shown entomological transmission indices above the criteria and standards of the World Health Organization (WHO).
The aim of our study is to implement and evaluate different strategies to control Aedes mosquitoes at different stages of their life cycle in the city of Kinshasa.
In particular, a before-and-after interventional study will be piloted and tested in the health zone of Kinshasa, with the aim of providing preliminary evidence of the impact of vector control tools.
Interventions will be implemented in 400 households for each arm for 12 months. Before, after and during the interventions, entomological surveys will be conducted in 160 households in each arm to define the density of the vectors. Mosquitoes will be tested for the possible presence of arbovirus RNA (dengue, chikungunya, Zika, yellow fever). During the pre-intervention period, a serological survey for the same diseases transmitted by the Aedes mosquito will be conducted on a sample of 450 people included in two health centers of reference for the health zone of Mont Ngafula 1. A questionnaire will also be administered before and after the intervention implementation to assess the community's knowledge, attitudes and practices towards Aedes mosquito vector control and Aedes-borne diseases.
The integration of the data collected within the scope of this study will provide an assessment of the feasibility and impact of the tested methods on entomological indicators, as well as determining the exposure and knowledge of Aedes-borne diseases in the Mont Ngafula 1 area.
Conditions
- Aedes-borne Diseases
Interventions
- BEHAVIORAL
-
Community-based environmental management
This intervention will be performed by the local community, who will have been previously informed and trained on the appropriate environmental management methods for the control of the Aedes mosquito. It will be based on the following elements: i) identification and removal of all artificial sources of reproduction of the Aedes mosquito inside and around the house (i.e. covering abandoned containers and/or storage containers to avoid water accumulation); ii) regular collection and disposal of household waste; iii) identification and resolution of all artificial sources of reproduction of the Aedes vector in or around the house (i.e. natural cavities such as tree holes will be filled to prevent water accumulation). This intervention will be carried out as a single intervention in Arm 1, in combination with a larvicidal intervention in Arm 2 and in combination with the intervention against the adult stage of the Aedes mosquito in Arm 3.
- OTHER
-
Vector control against immature stages of Aedes
Larvicidal control will be carried out through pyriproxifen-based autodissemination stations combined with Beauveria bassiana, implemented according to the manufacturer's recommended procedures.
- OTHER
-
Vector control against the mature stages of Aedes
The control of the adult Aedes mosquitoes will be carried out through mass trapping using BG-GAT traps implemented according to the manufacturer's recommended procedures. In each household, three traps will be deployed.
Sponsors & Collaborators
-
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
collaborator OTHER -
Institute of Tropical Medicine, Belgium
lead OTHER
Principal Investigators
-
Veerle Vanlerberghe · Institute of Tropical Medicine Antwerp
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-26
- Primary Completion
- 2026-09-30
- Completion
- 2026-12-31
Countries
- Democratic Republic of the Congo
Study Locations
More Related Trials
-
Prevalence of LF Infection in Districts Not Included in LF Control Activities
NCT03131401 ·Status: COMPLETED
-
Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention Study
NCT06698510 ·Status: RECRUITING
-
Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase
NCT00906880 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monitoring
NCT04099628 ·Status: COMPLETED ·Phase: NA
-
Western Kenya Integrated COVID-19 Response
NCT04501458 ·Status: UNKNOWN ·Phase: NA
-
Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects
NCT05256017 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assessment of Recombinant HAT-RDT Specificity
NCT05637632 ·Status: COMPLETED
-
Validation of INSPiRED Innovative Smart Diagnostic Devices for the Detection of Parasites Infections.
NCT04505046 ·Status: UNKNOWN
-
Ivermectin Treatment of Persons With Onchocerciasis-associated Epilepsy
NCT03852303 ·Status: COMPLETED ·Phase: PHASE4
-
Research for Elimination of Lymphatic Filariasis (ICIDR)
NCT00406627 ·Status: COMPLETED
-
Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis
NCT00146627 ·Status: COMPLETED ·Phase: PHASE3
-
Plasmodium and Other Parasites in Pregnant Women and Children Around Margibi and Montserrado Counties, Liberia
NCT03719599 ·Status: COMPLETED
-
Epidemiology and Control of Mansonella Perstans Infection in Uganda
NCT00215280 ·Status: COMPLETED ·Phase: NA
-
Integrating Community Interventions to Eliminate Neglected Tropical Diseases
NCT03667079 ·Status: COMPLETED ·Phase: NA
-
Seroprevalence of Leptospirosis in Val Müstair, Switzerland
NCT05300425 ·Status: COMPLETED
-
Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis
NCT03876262 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Cimex Lectularius or Bed Bugs : Vector of Infectious Agents and Pathogenic Role
NCT01089465 ·Status: COMPLETED ·Phase: NA
-
West Nile Virus Natural History
NCT00138463 ·Status: COMPLETED
-
Development of a New Rapid Diagnostic Test to Support Onchocerciasis Elimination
NCT06350851 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana
NCT02078024 ·Status: COMPLETED ·Phase: PHASE3
-
Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy
NCT03052998 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali
NCT02784743 ·Status: COMPLETED ·Phase: PHASE4
-
Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis
NCT01593722 ·Status: COMPLETED ·Phase: PHASE4
-
Lymphatic Filariasis (LF) in Ivory Coast
NCT02974049 ·Status: COMPLETED ·Phase: NA
-
Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria
NCT04672577 ·Status: NOT_YET_RECRUITING